Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness. - Wikidata - awgldk - TriplyDB

Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness.

Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness.

http://www.wikidata.org/entity/Q36161355

about

Intraoperative near-infrared imaging can distinguish cancer from normal tissue but not inflammation Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice.Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma.Intraoperative near-infrared imaging of surgical wounds after tumor resections can detect residual disease.Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery Intraprostatic distribution and long-term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer.Vaccine strategies for glioblastoma: progress and future directions.History of myeloid-derived suppressor cells.Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets.Cytoreductive prostatectomy in metastatic prostate cancer: a systematic review.Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults.Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations.The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer.Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma.γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi-institutional study of 62 patients.Local Immunotherapy of Cancer: Innovative Approaches to Harnessing Tumor-Specific Immune Responses.[Cytoreductive radical prostatectomy for prostate cancer with minimal osseous metastases: results of a first feasibility and case control study].

P2860

Q33968244-5E37B18F-4BAC-4B67-A5AF-A0B8BD9ED284 Q35506478-D4A65A8F-E7EA-42C3-B81F-CC9063DC24E5 Q35768107-D99DA308-8D22-4238-867C-84AA9808EF60 Q36351260-EEADE558-120D-402E-8035-8E2BFCFC2C02 Q36583022-8F697929-FFCD-4ED5-BDD0-836D5866EF85 Q37347492-6F32201A-6CA0-4F82-BF3E-8083B6686B8B Q38081910-AF6EBA77-9651-46AC-ABDB-1B200B8E4E5E Q38141522-8C125A1A-A977-45E0-9C10-DFB3701030B7 Q38269370-DC8B8988-DB29-4CC3-88BF-96ADCA3346D3 Q38619677-8100FA2A-8A1C-424B-B52A-9AB6907A8CA2 Q38654099-ABEFEADD-0630-43D3-ACA7-B4E9173D83D8 Q38912327-7929F575-CC56-4345-BFF5-E10CC0F617A5 Q38977428-073F681D-A2C7-4DE2-B939-8DC9FE3611B4 Q41566002-D2DA683F-BF77-4E6E-B5FD-C9B3E6421582 Q42153454-7FEE09F0-7E4F-4870-83F6-B6D5A28FB51F Q48164135-F4D38519-7568-43B7-8675-4CC1D985B3D1 Q50881510-BB302079-695B-48CB-BF7A-3F2DB755D125 Q52353493-DF4D382C-E129-4A61-BB43-FF4D7DEF257A Q53658743-CD86C8B1-44B2-43F2-AFCA-F6C2A5208ECB

P2860

Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness.

http://www.wikidata.org/entity/Q36161355

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Cytoreduction surgery reduces ...... l immunotherapy effectiveness.

@ast

Cytoreduction surgery reduces ...... l immunotherapy effectiveness.

@en

type

label

Cytoreduction surgery reduces ...... l immunotherapy effectiveness.

@ast

Cytoreduction surgery reduces ...... l immunotherapy effectiveness.

@en

prefLabel

Cytoreduction surgery reduces ...... l immunotherapy effectiveness.

@ast

Cytoreduction surgery reduces ...... l immunotherapy effectiveness.

@en

P1433

Q36161355-EBC83448-3398-4422-919D-6049AEE6A395

P1476

Q36161355-F5BC0035-44EE-4FAC-8448-F546F60049E3

P2093

Q36161355-01571429-3746-46EB-81F2-A0E51AB9B448

Q36161355-591A949C-D762-417B-87C4-26B45986D293

Q36161355-76F561AB-650A-4360-AF6E-C5AD466C8F42

Q36161355-A26E708C-134C-4B66-B22B-2B38F65D4851

Q36161355-A572BA94-4BF5-47C5-BF6C-5AF23167BBB8

Q36161355-A7433FA3-9D9C-4B1D-B16B-D54F6D04E082

Q36161355-D2ABCF5D-8ED6-4070-AF8D-99E6C6B44435

P2860

Q36161355-00BAFBBA-9CC9-4F26-928E-2D75160F6E27

Q36161355-0DE7CB7D-A53F-440A-A4DD-D8B9A494A60D

Q36161355-1131A4BC-7461-4165-B935-5BF6E2E1567C

Q36161355-1F41B0BF-16F7-4A0D-B138-4AC9145291A5

Q36161355-1F701F06-1323-49C1-BB39-52273FFE32C8

Q36161355-2FA9061E-1FAA-4D64-9009-32F4EECBA652

Q36161355-378BD226-705C-4397-8F36-9D2A8F0B0B05

Q36161355-40E34EB3-0A7C-440F-A1FF-6A3ADE3BEBC6

Q36161355-419C9B96-EE41-493D-984C-59DA891CAB88

Q36161355-56B07228-C766-4A52-ADE1-EBFCC018A24A

P2888

Q36161355-70F656A2-82A9-4480-96DE-5350EB5E71B0

P304

Q36161355-2DA97FCC-DDB8-4322-836B-7EDD52B0474E

P31

Q36161355-8761A088-CC5C-41AB-B301-36FE88EB8A29

P356

Q36161355-B3A183C9-F130-4794-9BD9-A4536137B6BE

P478

Q36161355-F5B8FF3A-6E3E-497E-9DA3-8938F26A71C2

P577

Q36161355-8F2841F1-78AD-470E-B9EF-974F8C622C9E

P5875

Q36161355-9BB23409-D7AE-47FE-BB98-6B7E7280395F

P6179

Q36161355-539E33A3-03F8-4854-AD1B-BEFB63153A81

P698

Q36161355-7CBCAA28-F145-4EE7-BFBF-101B5C25F6EB

P932

Q36161355-ADD9D71C-A43C-46E2-8FDD-A10A292692AA

P356

P1433

Journal of Hematology & Oncology

P1476

Cytoreduction surgery reduces ...... l immunotherapy effectiveness.

@en

P2093

Brendan F Judy

http://www.w3.org/2001/XMLSchema#string

Guanjun Cheng

http://www.w3.org/2001/XMLSchema#string

Jarrod D Predina

http://www.w3.org/2001/XMLSchema#string

Steven M Albelda

http://www.w3.org/2001/XMLSchema#string

Sunil Singhal

http://www.w3.org/2001/XMLSchema#string

Veena Kapoor

http://www.w3.org/2001/XMLSchema#string

Zvi Gregory Fridlender

http://www.w3.org/2001/XMLSchema#string

P2860

Myeloid-derived suppressor cells as regulators of the immune system

Regulatory T cells: a new frontier in cancer immunotherapy.

A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma.

Reversal of tumor-induced immunosuppression by TGF-beta inhibitors.

Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models.

Derangement of immune responses by myeloid suppressor cells.

Cancer immunotherapy and preclinical studies: why we are not wasting our time with animal experiments.

A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation.

Immune surveillance against a solid tumor fails because of immunological ignorance.

Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo

P2888

P304

34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-8722-5-34

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228086549

http://www.w3.org/2001/XMLSchema#string

P6179

1035063244

http://www.w3.org/2001/XMLSchema#string

P698

22742411

http://www.w3.org/2001/XMLSchema#string

P932

3418164

http://www.w3.org/2001/XMLSchema#string